Unigene Laboratories, Inc. (UGNE.OB) Appoints Ashleigh Palmer to CEO Position
Unigene Laboratories, Inc. (UGNE) www.unigene.com – a leading biopharma developer focused on novel oral and nasal delivery systems for large-market peptide drugs, with specific emphasis on the huge and quickly growing osteoporosis market – announced today the appointment of Ashleigh Palmer to President and CEO of the Company. Palmer, who will be taking over for Dr. Warren Levy, was also appointed to the Board of Directors, a dual role which will allow him to bring his vast expertise in health care industry field operations, and his proven track record of nurturing R&D/commercial capacities, into play. Chairman of the Board at…